Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations

Robert E. Shaddy, Scott Denne

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

The proper ethical conduct of studies to evaluate drugs in children is of paramount importance to all those involved in these types of studies. This report is an updated revision to the previously published guidelines from the American Academy of Pediatrics in 1995. Since the previous publication, there have been great strides made in the science and ethics of studying drugs in children. There have also been numerous legislative and regulatory advancements that have promoted the study of drugs in children while simultaneously allowing for the protection of this particularly vulnerable group. This report summarizes these changes and advances and provides a framework from which to guide and monitor the ethical conduct of studies to evaluate drugs in children.

Original languageEnglish (US)
Pages (from-to)850-860
Number of pages11
JournalPediatrics
Volume125
Issue number4
DOIs
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

Guidelines
Pediatrics
Pharmaceutical Preparations
Population
Ethics

Keywords

  • Children
  • Drugs
  • Ethics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. / Shaddy, Robert E.; Denne, Scott.

In: Pediatrics, Vol. 125, No. 4, 04.2010, p. 850-860.

Research output: Contribution to journalArticle

@article{05586815254b4084925bf18183d00a83,
title = "Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations",
abstract = "The proper ethical conduct of studies to evaluate drugs in children is of paramount importance to all those involved in these types of studies. This report is an updated revision to the previously published guidelines from the American Academy of Pediatrics in 1995. Since the previous publication, there have been great strides made in the science and ethics of studying drugs in children. There have also been numerous legislative and regulatory advancements that have promoted the study of drugs in children while simultaneously allowing for the protection of this particularly vulnerable group. This report summarizes these changes and advances and provides a framework from which to guide and monitor the ethical conduct of studies to evaluate drugs in children.",
keywords = "Children, Drugs, Ethics",
author = "Shaddy, {Robert E.} and Scott Denne",
year = "2010",
month = "4",
doi = "10.1542/peds.2010-0082",
language = "English (US)",
volume = "125",
pages = "850--860",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4",

}

TY - JOUR

T1 - Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations

AU - Shaddy, Robert E.

AU - Denne, Scott

PY - 2010/4

Y1 - 2010/4

N2 - The proper ethical conduct of studies to evaluate drugs in children is of paramount importance to all those involved in these types of studies. This report is an updated revision to the previously published guidelines from the American Academy of Pediatrics in 1995. Since the previous publication, there have been great strides made in the science and ethics of studying drugs in children. There have also been numerous legislative and regulatory advancements that have promoted the study of drugs in children while simultaneously allowing for the protection of this particularly vulnerable group. This report summarizes these changes and advances and provides a framework from which to guide and monitor the ethical conduct of studies to evaluate drugs in children.

AB - The proper ethical conduct of studies to evaluate drugs in children is of paramount importance to all those involved in these types of studies. This report is an updated revision to the previously published guidelines from the American Academy of Pediatrics in 1995. Since the previous publication, there have been great strides made in the science and ethics of studying drugs in children. There have also been numerous legislative and regulatory advancements that have promoted the study of drugs in children while simultaneously allowing for the protection of this particularly vulnerable group. This report summarizes these changes and advances and provides a framework from which to guide and monitor the ethical conduct of studies to evaluate drugs in children.

KW - Children

KW - Drugs

KW - Ethics

UR - http://www.scopus.com/inward/record.url?scp=77950583461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950583461&partnerID=8YFLogxK

U2 - 10.1542/peds.2010-0082

DO - 10.1542/peds.2010-0082

M3 - Article

VL - 125

SP - 850

EP - 860

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -